Kelvin Chan

Experienced Pharmaceutical R&D Leader in DMPK and CMC

Dallas-Fort Worth Metroplex

About

Pharmaceutical R&D professional with excellent combination of scientific acumen and management skills who has consistently made significant contributions to successful discovery research, development, and product life cycle management projects: • Contributed to the discovery or development of 7 NMEs to successful NDAs • Proven ability to liaise multi-disciplinary and multi-national teams to deliver innovative solutions to meet corporate objectives in a matrix organization • Demonstrated continuous learning abilities to expand skills and responsibilities • Strategic leader with excellent analytical and problem solving skills • Managed diversity, organizational changes, and staff development Specialties: Preclinical Optimization, Early Clinical Development, Drug Metabolism/Pharmacokinetics, PK/PD, Analytical Sciences in CMC, Bioanalytical, GLP and cGMP, spectroscopy, chromatography/mass spectrometry, scientific and business coordination

Experience

  • Member Board Of Directors at Nano Tech Pharma Inc
    Jul 2021 - Present · 5 yrs 1 mo

  • Principal at Harvest Consulting LLC
    Sep 2018 - Present · 7 yrs 11 mos

  • Director, DMPK at DeepCure Inc
    Feb 2022 - Dec 2024 · 2 yrs 11 mos

    Employ AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.

  • Senior Director DMPK at Assembly Biosciences, Inc.
    Jan 2017 - Aug 2018 · 1 yr 8 mos

  • Head, Pharmacokinetics / Pharmacodynamics at Alcon, a Novartis company
    Jan 2014 - Dec 2016 · 3 yrs

    -Led a group of experienced scientists to represent DMPK on cross functional project teams -Developed, planned, and implemented clinical and nonclinical DMPK, PK/PD, and Clinical Pharmacology strategies for small molecule and biotherapeutic drug candidates from early discovery to life cycle management -Collaborated with functional groups and project management to deliver project milestones -Reviewed ADME, PK/PD, and Clinical Pharmacology sections of regulatory documents